NASDAQ:ORIC | Free Cash Flow | Oric Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$32.44M$2,000.00-$32.44M
2025-12-31-$22.48M$227,000.00-$22.71M
2025-03-31-$32.53M$387,000.00-$32.92M
2024-12-31-$28.05M$219,000.00-$28.27M
2024-03-31-$30.19M$218,000.00-$30.4M
2023-12-31-$24.27M$57,000.00-$24.33M
2023-03-31-$20.63M$310,000.00-$20.94M
2022-12-31-$15.33M$287,000.00-$15.62M
2022-03-31-$22.72M$723,000.00-$23.44M
2021-12-31-$16.28M$389,000.00-$16.67M
2021-03-31-$14.9M$182,000.00-$15.08M
2020-12-31-$17.83M$411,000.00-$18.24M
2020-03-31-$8.28M$4,000.00-$8.28M
2019-12-31-$7.15M$56,000.00-$7.2M
2019-03-31-$5.53M$100,000.00-$5.63M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$110.97M$712,000.00-$111.68M
2024-12-31-$112.66M$1.19M-$113.85M
2023-12-31-$85.69M$849,000.00-$86.54M
2022-12-31-$75.14M$2.08M-$77.22M
2021-12-31-$59.54M$939,000.00-$60.48M
2020-12-31-$45.27M$667,000.00-$45.94M
2019-12-31-$23.53M$768,000.00-$24.3M
2018-12-31-$20.68M$525,000.00-$21.21M